跳至主要内容
临床试验/JPRN-jRCT2080224839
JPRN-jRCT2080224839终止3 期

A combination study on WP-1303 or placebo and timolol ophthalmic solution in patients with primary open-angle glaucoma (POAG) or ocular hypertension (OH)

Wakamoto pharmaceutical Co., Ltd.0 个研究点目标入组 180 人开始时间: 2019年8月20日最近更新:
适应症

试验速览

阶段
3 期
状态
终止
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • Patients with POAG or OH.
  • IOP is less than 35mmHg for both eyes.
  • IOP aftre timolol treated is greater than or equal 18mmHg.

排除标准

  • Patients who have visual acuity of less than 0.3.
  • Presence of active eye disease (eg., uveitis, ocular infection, severe dry eye).
  • Pregnant women, lactating women or women who desire to be pregnant.
  • Patients who is judged inappropriate to participate in the study by investigator or sub-investigator.

研究者

相似试验